FindTrial
Sign In

Daikenchuto (TU-100)

DRUG5 trials

Sponsors

Tsumura USA

Conditions

Abdominal PainColonic TransitDigestive System DiseasesFunctional ConstipationGastric EmptyingGastrointestinal DiseasesIntestinal DiseasesIrritable Bowel Syndrome

Phase 1

Effect of TU-100 on Gastrointestinal and Colonic Transit in Humans
CompletedNCT00871325
Tsumura USAPostoperative Ileus
Start: 2009-06-30End: 2010-01-31Updated: 2013-01-14
Effect of TU-100 on Rectal Compliance, Rectal Sensation and Small Bowel and Colonic Transit in Females With Constipation
CompletedNCT01139216
Tsumura USAColonic Transit, Functional Constipation, Gastric Emptying +4
Start: 2010-08-31End: 2012-11-30Updated: 2013-01-14
Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS)
CompletedNCT01890837
Tsumura USAAbdominal Pain, Digestive System Diseases, Gastrointestinal Diseases +2
Start: 2013-08-31End: 2015-03-31Updated: 2016-06-13

Phase 2

Effect of TU-100 in Patients With Functional Constipation
CompletedNCT01348152
Tsumura USAFunctional Constipation
Start: 2011-09-30End: 2013-07-31Updated: 2013-09-17
Effect of TU-100 in Patients Undergoing Laparoscopic Colectomy
CompletedNCT02232893
Tsumura USAPostoperative Ileus
Start: 2014-09-30End: 2017-05-31Updated: 2020-06-19

Related Papers

Randomised clinical trial: the effects of daikenchuto, TU-100, on gastrointestinal and colonic transit, anorectal and bowel function in female patients with functional constipation.
2013-03-0435 citations